August 05, 2025

Periodontal Disease: Systemic Associations Across Multiple Organ Systems

Evidence links periodontal inflammation to systemic dysfunction across cardiovascular, endocrine, renal, respiratory, and neurologic systems.

Conexiant

July 30, 2025

Mortality Among Surgeons in the United States 

National mortality data reveal that surgeons face higher death rates than non-surgeon physicians, with cancer and external causes contributing prominently.

Conexiant

August 01, 2025

UTI Linked to Short-Term Spike in MI, Storke

Analysis of microbiologically confirmed UTIs reveals a transient increase in cardiovascular event rates, especially within 7 days of infection onset.

Conexiant

August 01, 2025

Consistent or Increasing Physical Activity Across Adulthood Linked to Lower Mortality

This large meta-analysis on physical activity patterns and mortality—encompassing 85 prospective cohort studies—shows that consistent or increasing physical activity during adulthood is associated with lower all-cause and cardiovascular mortality risk.

Conexiant

July 31, 2025

Triple Cardiovascular Therapy Linked With Slower Cognitive Decline

Combination use of antihypertensive, lipid-lowering, and antidiabetic agents shows associations with cognitive preservation and postmortem neuropathologic changes in aging cohorts.

Conexiant

July 30, 2025

JAK Inhibitors May Improve Artery Health Markers

JAK inhibitor therapy targets inflammation and correlates with improvements in carotid artery measurements, while baseline vascular markers continue to predict cardiovascular risk.

Conexiant

July 28, 2025

Top 10 States to Practice Cardiology

A state-by-state guide for cardiologists seeking the most rewarding places to build their careers, blending compensation, lifestyle, and growth potential.

Conexiant

July 25, 2025

NOACs Linked to Higher Post-TAVR Risk 

Researchers assess post-TAVR antithrombotic strategies, finding that discharge therapy choice impacts early and late clinical outcomes in a diverse patient cohort.

Conexiant

July 25, 2025

Tofacitinib Curbs Inflammation, Not Thrombosis Risk

Tofacitinib dampens inflammatory cytokine production in rheumatoid arthritis models but fails to counteract endothelial prothrombotic responses, highlighting ongoing cardiovascular safety concerns.

Conexiant